WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 4 fonti

India moves to diversify pharma exports & cut US market dependence, eyes $130 billion target by 2030

Commerce ministry kicks off measures to insulate drug makers in wake of West Asia crisis. Renewed focus on Europe, Latin America, Africa among steps to grow ‘pharmacy of the world’.

Raccontata daeconomictimes.indiatimes.comthehindubusinessline.comthehindu.comtheprint.in

Confronto fonti

4 prospettive sulla stessa storia
AI · summaries
theprint.inStai leggendo20 h fa

India moves to diversify pharma exports & cut US market dependence, eyes $130 billion target by 2030

India targets $130B pharma exports by 2030 through Southeast Asia hubs and market diversification, reducing US dependency from 33%. The supply-chain pivot signals healthcare sovereignty; watch regulatory harmonization, vendor risks, and SaaS logistics opportunities in new pharma hubs.

originale
thehindubusinessline.com1 g fa

Pharma exports to clock $50 billion by 2030: Ministry official

India's pharma exports are set to reach $50 billion by 2030, driven by affordability and global market diversification.

Leggi questa versione → originale
economictimes.indiatimes.com1 g fa

Govt outlines next phase of pharma growth

The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 2030. Focus remains on quality, affordability, and continuity in global…

Leggi questa versione → originale
thehindu.com2 g fa

India may extend duty exemptions on pharma inputs beyond June 30

India is reviewing the months-old duty-related relief measures for pharma sector amid the evolving situation in West Asia and likely to extend the exemptions beyond June 30, a senior official in the Centre’s Department…

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 8 giugno 2026·economictimes.indiatimes.com

    India willing to open its market to high-quality, innovative pharma products, says commerce minister

    India is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug exports. The Indian pharma market is set…

  2. lunedì 8 giugno 2026·thehindubusinessline.com

    India ready to open pharma market to innovative global products: Goyal

    India is willing to open its pharma market to innovative products while seeking better access for drug exports, says Commerce Minister Piyush Goyal.

  3. martedì 9 giugno 2026·thehindu.com

    India may extend duty exemptions on pharma inputs beyond June 30

    India is reviewing the months-old duty-related relief measures for pharma sector amid the evolving situation in West Asia and likely to extend the exemptions beyond June 30, a…

  4. mercoledì 10 giugno 2026·thehindubusinessline.com

    Pharma exports to clock $50 billion by 2030: Ministry official

    India's pharma exports are set to reach $50 billion by 2030, driven by affordability and global market diversification.

  5. mercoledì 10 giugno 2026·economictimes.indiatimes.com

    Govt outlines next phase of pharma growth

    The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 2030. Focus remains on quality,…

  6. giovedì 11 giugno 2026·theprint.in

    India moves to diversify pharma exports & cut US market dependence, eyes $130 billion target by 2030

    Commerce ministry kicks off measures to insulate drug makers in wake of West Asia crisis. Renewed focus on Europe, Latin America, Africa among steps to grow ‘pharmacy of the…